TLPH: Talphera, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 19.34
Enterprise Value ($M) 13.62
Book Value ($M) 14.11
Book Value / Share 0.83
Price / Book 1.37
NCAV ($M) 5.27
NCAV / Share 0.31
Price / NCAV 3.67

Profitability (mra)
Return on Invested Capital (ROIC) -1.30
Return on Assets (ROA) -0.70
Return on Equity (ROE) -1.29

Liquidity (mrq)
Quick Ratio 2.56
Current Ratio 2.56

Balance Sheet (mrq) ($M)
Current Assets 11.56
Assets 20.39
Liabilities 6.29
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.65
Operating Income -16.89
Net Income -18.40
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -17.49
Cash from Investing -0.53
Cash from Financing 3.47

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 3.01
02-13 13G/A Lind Global Fund II LP 4.20
01-23 13D Nantahala Capital Management, LLC 11.80 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-12 4,028 30,130 13.37
2024-04-11 15,041 6,833 220.12
2024-04-10 8,084 50,670 15.95
2024-04-09 7,119 70,484 10.10
2024-04-08 12,621 87,159 14.48

(click for more detail)

Similar Companies
TCRX – TScan Therapeutics, Inc. TENK – TenX Keane Acquisition
TKNO – Alpha Teknova, Inc. TNGX – Tango Therapeutics, Inc.
TRDA – Entrada Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io